Last update Dec. 20, 2022
Very Low Risk
Lisovyr is a tradename that contains a main active ingredient in its composition:
For more information (pharmacokinetics, references, ...) tap the name of the active ingredient.
Note: The composition of certain tradenames varies in each country. Please, make sure this is the composition of the tradename you are looking for..
We do not have alternatives for Lisovyr since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM